| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | +2251.0% |
| R&D Expense | $173.6M | +28.4% |
| SG&A Expense | $40.8M | +17.0% |
| Operating Income | -$210.8M | -24.1% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$187.1M | -22.3% |
| Income Tax | $300K | — |
| Net Income | -$187.4M | -22.5% |
| EPS (Basic) | -$5.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $559.9M | +69.1% |
| Accounts Receivable | $2.7M | +1817.5% |
| Current Assets | $588.9M | +69.6% |
| Total Assets | $615.9M | +66.4% |
| Current Liabilities | $27.4M | +12.6% |
| Total Liabilities | $44.3M | +17.2% |
| Stockholders' Equity | $571.6M | +72.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$160.9M | -29.2% |
| Capital Expenditures | $1.9M | -21.6% |
| Investing Cash Flow | -$1.9M | +21.6% |
| Financing Cash Flow | $391.8M | +118.9% |
| Free Cash Flow | -$162.8M | -28.2% |
| +3.8% |
| EPS (Diluted) | -$5.00 | +3.8% |